Pharmaceutical manufacturing has embraced automation, but automation alone doesn't create operational visibility. The next challenge is connecting the systems that already exist.
But one issue that still persists and does not allow these systems to reach their full potential is disconnected operational data.
Production teams have access to equipment logs, inventories, environmental data, workforce data, and quality data – but they are dispersed across various systems. Consequently, engineers and operations teams lose time collecting information rather than finding solutions.
This is where Artificial Intelligence of Things comes into play.
The Problem Is Not Data - It Is The Connectivity Of Data
Today's pharmaceutical manufacturing sites produce thousands of operational events daily.
Such events include:
Equipment condition and performance
cleanroom environmental monitoring
inventory transactions
material movement
workforce activities
Batch genealogy
Quality checks
Assets' utilization
Each of these systems performs their task well, but when their datasets are not connected, it becomes challenging to have a complete picture of the manufacturing operations.
Thus, manufacturers have:
Delayed problem-solving
Manual reporting
Reduced operational visibility
Delayed decisions
Increased compliance efforts
More dashboards don't solve fragmented operations. Connecting existing data does. Integration of existing operational data is needed.
How AIoT Connects Manufacturing Systems
AIoT brings together Industrial IoT devices, connected sensors, RFID, Bluetooth Low Energy (BLE), artificial intelligence, and real-time analytics into a unified operational platform.
Unlike other systems that operate independently, AIoT connects different manufacturing events to each other.
A production manager can, for instance, correlate:
equipment performance
Activities of employees
Environmental conditions
Inventory status
Materials flow
Batch records
production progress
Connected operational context is a better way to understand what happens at the facility.
Why Traceability Is Benefited from Connected Operational Data
Traceability is one of the most critical requirements for pharmaceutical manufacturing.
Every pharmaceutical batch is influenced by raw materials, production parameters, equipment, operators, environmental conditions, and quality inspections.
Without connected systems, tracing of manufacturing issue involves collecting information from several applications.
AIoT platform makes it much easier by connecting manufacturing events in a chain of operational processes to facilitate retrieving of production records and regulatory compliance.
AI Helps to Make a Decision but Does Not Take Decisions
Artificial intelligence is most efficient at analysing connected operational data.
Instead of automating manufacturing specialists out of their jobs, AI assists in finding out the following:
Trends in the equipment performance
Patterns in the inventory consumption
Production bottlenecks
Maintenance forecasts
Anomalies in operations
This information allows decision-making to be faster and more informed while specialist teams still take care of the complex aspects of manufacturing and quality control.
Looking Ahead
Pharmaceutical manufacturing digital transformation proceeds from mere automation to connected operational intelligence.
Those who combine their equipment, workforce, inventory, environment monitoring, and production data can benefit greatly from improved visibility, efficiency, and compliance.
The next level of the Industry 4.0 development is not about producing any more manufacturing data – it's about linking already existing data to produce actionable operational intelligence.
For those who are interested in seeing how connected AIoT platforms are used in pharmaceutical manufacturing, PharmaFlux AI gives you an insight on modern solutions of manufacturing visibility and operational intelligence improvement: https://pharmafluxai.com/
As manufacturing becomes more connected, As manufacturing environments become increasingly connected, organizations that transform fragmented operational data into actionable intelligence will be better equipped to improve productivity, maintain compliance, and consistently deliver high-quality pharmaceutical products.
Top comments (0)